Completed NA INTERVENTIONAL 3-arm NCT01640184

Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients

Study of the Efficacy and Safety on the Ultrasonic Ablation Treatment for Secondary Hyperthyroidism in Chronic Kidney Disease Patients.

Sponsor: Beijing Municipal Science & Technology Commission

Conditions Disorders of Parathyroid Gland Hyperparathyroidism

Interventions Active vitamin D Parathyroidectomy Ultrasonic ablation

Updated 5 times since 2017 Last updated: Aug 23, 2016 Started: Aug 31, 2012 Primary completion: Nov 30, 2014 Completion: Nov 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Disorders of Parathyroid Gland and Hyperparathyroidism and is currently completed. Beijing Municipal Science & Technology Commission leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Municipal Science & Technology Commission
Dongliang Zhang, MD

Data source: Capital Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China